93 related articles for article (PubMed ID: 23029524)
1. Bmi1 drives the formation and development of intrahepatic cholangiocarcinoma independent of Ink4A/Arf repression.
Guo J; Deng N; Xu Y; Li L; Kuang D; Li M; Li X; Xu Z; Xiang M; Xu C
Pharmacol Res; 2021 Feb; 164():105365. PubMed ID: 33307220
[TBL] [Abstract][Full Text] [Related]
2. BMI1 is required for melanocyte stem cell maintenance and hair pigmentation.
Wilson MM; Danielian PS; Salus G; Ferretti R; Whittaker CA; Lees JA
Pigment Cell Melanoma Res; 2023 Sep; 36(5):399-406. PubMed ID: 37132544
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF.
Kranc KR; Bamforth SD; Bragança J; Norbury C; van Lohuizen M; Bhattacharya S
Mol Cell Biol; 2003 Nov; 23(21):7658-66. PubMed ID: 14560011
[TBL] [Abstract][Full Text] [Related]
4. Bmi1 Augments Proliferation and Survival of Cortical Bone-Derived Stem Cells after Injury through Novel Epigenetic Signaling via Histone 3 Regulation.
Kraus L; Bryan C; Wagner M; Kino T; Gunchenko M; Jalal W; Khan M; Mohsin S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360579
[TBL] [Abstract][Full Text] [Related]
5. Bmi1 Regulates Wnt Signaling in Hematopoietic Stem and Progenitor Cells.
Yu H; Gao R; Chen S; Liu X; Wang Q; Cai W; Vemula S; Fahey AC; Henley D; Kobayashi M; Liu SZ; Qian Z; Kapur R; Broxmeyer HE; Gao Z; Xi R; Liu Y
Stem Cell Rev Rep; 2021 Dec; 17(6):2304-2313. PubMed ID: 34561772
[TBL] [Abstract][Full Text] [Related]
6. BMI1 in the heart: Novel functions beyond tumorigenesis.
Yang D; Liu HQ; Yang Z; Fan D; Tang QZ
EBioMedicine; 2021 Jan; 63():103193. PubMed ID: 33421944
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
[TBL] [Abstract][Full Text] [Related]
8. Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma.
Badodi S; Dubuc A; Zhang X; Rosser G; Da Cunha Jaeger M; Kameda-Smith MM; Morrissy AS; Guilhamon P; Suetterlin P; Li XN; Guglielmi L; Merve A; Farooq H; Lupien M; Singh SK; Basson MA; Taylor MD; Marino S
Cell Rep; 2017 Dec; 21(10):2772-2784. PubMed ID: 29212025
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.
Gisler S; Maia ARR; Chandrasekaran G; Kopparam J; van Lohuizen M
PLoS One; 2020; 15(4):e0227592. PubMed ID: 32343689
[TBL] [Abstract][Full Text] [Related]
10. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice.
Knight B; Yeoh GC; Husk KL; Ly T; Abraham LJ; Yu C; Rhim JA; Fausto N
J Exp Med; 2000 Dec; 192(12):1809-18. PubMed ID: 11120777
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin-facilitated invasion of BMI1-high hepatocellular carcinoma cells drives bile duct tumor thrombi formation.
Xu LB; Qin YF; Su L; Huang C; Xu Q; Zhang R; Shi XD; Sun R; Chen J; Song Z; Jiang X; Shang L; Xiao G; Kong X; Liu C; Wong PP
Nat Commun; 2023 Nov; 14(1):7033. PubMed ID: 37923799
[TBL] [Abstract][Full Text] [Related]
12. Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma.
Badodi S; Pomella N; Lim YM; Brandner S; Morrison G; Pollard SM; Zhang X; Zabet NR; Marino S
Neuro Oncol; 2022 Aug; 24(8):1273-1285. PubMed ID: 35213723
[TBL] [Abstract][Full Text] [Related]
13. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
Li L; Che L; Tharp KM; Park HM; Pilo MG; Cao D; Cigliano A; Latte G; Xu Z; Ribback S; Dombrowski F; Evert M; Gores GJ; Stahl A; Calvisi DF; Chen X
Hepatology; 2016 Jun; 63(6):1900-13. PubMed ID: 26910791
[TBL] [Abstract][Full Text] [Related]
14. BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner.
Liu Z; Hu C; Zheng L; Liu J; Li K; Li X; Wang Y; Mu W; Chen T; Shi A; Qiu B; Zhang X; Zhang Z; Xu Y
Cell Mol Life Sci; 2022 Aug; 79(9):469. PubMed ID: 35932322
[TBL] [Abstract][Full Text] [Related]
15. Bmi1 is required for hepatic progenitor cell expansion and liver tumor development.
Fan L; Xu C; Wang C; Tao J; Ho C; Jiang L; Gui B; Huang S; Evert M; Calvisi DF; Chen X
PLoS One; 2012; 7(9):e46472. PubMed ID: 23029524
[TBL] [Abstract][Full Text] [Related]
16. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
17. Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.
Xu CR; Lee S; Ho C; Bommi P; Huang SA; Cheung ST; Dimri GP; Chen X
Mol Cancer Res; 2009 Dec; 7(12):1937-45. PubMed ID: 19934271
[TBL] [Abstract][Full Text] [Related]
18. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M
Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558
[TBL] [Abstract][Full Text] [Related]
19. A protein synthesis brake for hematopoietic stem cell maintenance.
Lv K; Tong W
Genes Dev; 2022 Aug; 36(15-16):871-873. PubMed ID: 36207141
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
